Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)
A Three Part, Staggered Cohort, Open-label and Double Blind, Randomized, Placebo Controlled Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of Eltrombopag, a Thrombopoietin Receptor Agonist, in Previously Treated Pediatric Patients With Chronic ITP.
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Toronto,
Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)
A Three Part, Staggered Cohort, Open-label and Double Blind, Randomized, Placebo Controlled Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of Eltrombopag, a Thrombopoietin Receptor Agonist, in Previously Treated Pediatric Patients With Chronic ITP.
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Toronto,
Click here to add this to my saved trials
Pilot Study of a Catheter-based Ultrasound Hyperthermia System
Pilot Study of a Catheter-based Ultrasound Hyperthermia System
Status: Enrolling
Updated:  12/31/1969
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Pilot Study of a Catheter-based Ultrasound Hyperthermia System
Pilot Study of a Catheter-based Ultrasound Hyperthermia System
Status: Enrolling
Updated: 12/31/1969
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Host Factors in Invasive and Recurrent Staphylococcus Aureus Infection
Host Factors in Invasive and Recurrent Staphylococcus Aureus Infection
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Host Factors in Invasive and Recurrent Staphylococcus Aureus Infection
Host Factors in Invasive and Recurrent Staphylococcus Aureus Infection
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma
A Phase I/II Study of the Histone Deacetylase (HDAC) Inhibitor LBH589 (Panobinostat) in Combination With mTOR Inhibitor RAD001 (Everolimus) in Patients With Relapsed Multiple Myeloma or Lymphoma
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma
A Phase I/II Study of the Histone Deacetylase (HDAC) Inhibitor LBH589 (Panobinostat) in Combination With mTOR Inhibitor RAD001 (Everolimus) in Patients With Relapsed Multiple Myeloma or Lymphoma
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma
A Phase I/II Study of the Histone Deacetylase (HDAC) Inhibitor LBH589 (Panobinostat) in Combination With mTOR Inhibitor RAD001 (Everolimus) in Patients With Relapsed Multiple Myeloma or Lymphoma
Status: Enrolling
Updated:  12/31/1969
Mark O Hatfield-Warren Grant Magnuson Clinical Center
mi
from
Bethesda, MD
Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma
A Phase I/II Study of the Histone Deacetylase (HDAC) Inhibitor LBH589 (Panobinostat) in Combination With mTOR Inhibitor RAD001 (Everolimus) in Patients With Relapsed Multiple Myeloma or Lymphoma
Status: Enrolling
Updated: 12/31/1969
Mark O Hatfield-Warren Grant Magnuson Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma
A Phase I/II Study of the Histone Deacetylase (HDAC) Inhibitor LBH589 (Panobinostat) in Combination With mTOR Inhibitor RAD001 (Everolimus) in Patients With Relapsed Multiple Myeloma or Lymphoma
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma
A Phase I/II Study of the Histone Deacetylase (HDAC) Inhibitor LBH589 (Panobinostat) in Combination With mTOR Inhibitor RAD001 (Everolimus) in Patients With Relapsed Multiple Myeloma or Lymphoma
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Safety Surveillance Study of ACAM2000® Vaccinia Vaccine
A Phase IV Enhanced Safety Surveillance Study of ACAM2000® in Military Personnel
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Twentynine Palms, CA
Safety Surveillance Study of ACAM2000® Vaccinia Vaccine
A Phase IV Enhanced Safety Surveillance Study of ACAM2000® in Military Personnel
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Twentynine Palms, CA
Click here to add this to my saved trials
Safety Surveillance Study of ACAM2000® Vaccinia Vaccine
A Phase IV Enhanced Safety Surveillance Study of ACAM2000® in Military Personnel
Status: Enrolling
Updated:  12/31/1969
mi
from
Fort Campbell North, KY
Safety Surveillance Study of ACAM2000® Vaccinia Vaccine
A Phase IV Enhanced Safety Surveillance Study of ACAM2000® in Military Personnel
Status: Enrolling
Updated: 12/31/1969
mi
from
Fort Campbell North, KY
Click here to add this to my saved trials
Safety Surveillance Study of ACAM2000® Vaccinia Vaccine
A Phase IV Enhanced Safety Surveillance Study of ACAM2000® in Military Personnel
Status: Enrolling
Updated:  12/31/1969
mi
from
Fort Bliss, TX
Safety Surveillance Study of ACAM2000® Vaccinia Vaccine
A Phase IV Enhanced Safety Surveillance Study of ACAM2000® in Military Personnel
Status: Enrolling
Updated: 12/31/1969
mi
from
Fort Bliss, TX
Click here to add this to my saved trials
Safety Surveillance Study of ACAM2000® Vaccinia Vaccine
A Phase IV Enhanced Safety Surveillance Study of ACAM2000® in Military Personnel
Status: Enrolling
Updated:  12/31/1969
mi
from
Fort Hood, TX
Safety Surveillance Study of ACAM2000® Vaccinia Vaccine
A Phase IV Enhanced Safety Surveillance Study of ACAM2000® in Military Personnel
Status: Enrolling
Updated: 12/31/1969
mi
from
Fort Hood, TX
Click here to add this to my saved trials
A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)
An Open Label Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants
Status: Enrolling
Updated:  12/31/1969
Wesely Medical Center
mi
from
Wichita, KA
A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)
An Open Label Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Wesely Medical Center
mi
from
Wichita, KA
Click here to add this to my saved trials
A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)
An Open Label Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants
Status: Enrolling
Updated:  12/31/1969
Tulane School of Medicine
mi
from
New Orleans, LA
A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)
An Open Label Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Tulane School of Medicine
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)
An Open Label Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants
Status: Enrolling
Updated:  12/31/1969
Duke University
mi
from
Durham, NC
A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)
An Open Label Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma
A Phase II Prospective Non-Randomized Clinical Trial of Dose-Adjusted Schedule of Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma Who Did Not Receive Prior Systemic Therapy or Have Been Treated With Single Agent Targretin
Status: Enrolling
Updated:  12/31/1969
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma
A Phase II Prospective Non-Randomized Clinical Trial of Dose-Adjusted Schedule of Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma Who Did Not Receive Prior Systemic Therapy or Have Been Treated With Single Agent Targretin
Status: Enrolling
Updated: 12/31/1969
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma
A Phase I/II Multicenter Clinical Trial of O6Benzylguanine and Topical Carmustine in the Treatment of Refractory Early-Stage (IA-IIA) Cutaneous T-Cell Lymphoma
Status: Enrolling
Updated:  12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma
A Phase I/II Multicenter Clinical Trial of O6Benzylguanine and Topical Carmustine in the Treatment of Refractory Early-Stage (IA-IIA) Cutaneous T-Cell Lymphoma
Status: Enrolling
Updated: 12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma
A Phase I/II Multicenter Clinical Trial of O6Benzylguanine and Topical Carmustine in the Treatment of Refractory Early-Stage (IA-IIA) Cutaneous T-Cell Lymphoma
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve Univ
mi
from
Cleveland, OH
O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma
A Phase I/II Multicenter Clinical Trial of O6Benzylguanine and Topical Carmustine in the Treatment of Refractory Early-Stage (IA-IIA) Cutaneous T-Cell Lymphoma
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma
A Phase I/II Multicenter Clinical Trial of O6Benzylguanine and Topical Carmustine in the Treatment of Refractory Early-Stage (IA-IIA) Cutaneous T-Cell Lymphoma
Status: Enrolling
Updated:  12/31/1969
Case Comprehensive Cancer Center
mi
from
Cleveland, OH
O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma
A Phase I/II Multicenter Clinical Trial of O6Benzylguanine and Topical Carmustine in the Treatment of Refractory Early-Stage (IA-IIA) Cutaneous T-Cell Lymphoma
Status: Enrolling
Updated: 12/31/1969
Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma
A Phase I/II Multicenter Clinical Trial of O6Benzylguanine and Topical Carmustine in the Treatment of Refractory Early-Stage (IA-IIA) Cutaneous T-Cell Lymphoma
Status: Enrolling
Updated:  12/31/1969
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma
A Phase I/II Multicenter Clinical Trial of O6Benzylguanine and Topical Carmustine in the Treatment of Refractory Early-Stage (IA-IIA) Cutaneous T-Cell Lymphoma
Status: Enrolling
Updated: 12/31/1969
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
UCLA Pediatric Infectious Diseases
mi
from
Los Angeles, CA
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
UCLA Pediatric Infectious Diseases
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
University of Colorado Hospital Blood Donor Center
mi
from
Aurora, CO
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
University of Colorado Hospital Blood Donor Center
mi
from
Aurora, CO
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
Cornell Clinical Trials Unit, New York Presbyterian Hospital, Weill Cornell Medical College
mi
from
New York, NY
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
Cornell Clinical Trials Unit, New York Presbyterian Hospital, Weill Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
AIDS Clinical Trials Unit, NYU School of Medicine
mi
from
New York, NY
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
AIDS Clinical Trials Unit, NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
Clinical Translational Research Center (CTRC) at UNC Hospitals
mi
from
Chapel Hill, NC
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
Clinical Translational Research Center (CTRC) at UNC Hospitals
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
AIDS Clinical Trial Unit, Holmes Hospital, Div of Infectious Disease, University of Cincinnati College of Medicine
mi
from
Cincinnati, OH
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
AIDS Clinical Trial Unit, Holmes Hospital, Div of Infectious Disease, University of Cincinnati College of Medicine
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
UCLA CARE Ctr
mi
from
Los Angeles, CA
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
UCLA CARE Ctr
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
A Pilot Study of pnGVL4a-CRT/E7 (Detox) for the Treatment of Patients With HPV16+ Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
A Pilot Study of pnGVL4a-CRT/E7 (Detox) for the Treatment of Patients With HPV16+ Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
A Pilot Study of pnGVL4a-CRT/E7 (Detox) for the Treatment of Patients With HPV16+ Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Outpatient Center
mi
from
Baltimore, MD
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
A Pilot Study of pnGVL4a-CRT/E7 (Detox) for the Treatment of Patients With HPV16+ Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Outpatient Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
A Pilot Study of pnGVL4a-CRT/E7 (Detox) for the Treatment of Patients With HPV16+ Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
A Pilot Study of pnGVL4a-CRT/E7 (Detox) for the Treatment of Patients With HPV16+ Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Collection of Blood, Bone Marrow, Skin Biopsies and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols Laboratory Research Studies
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Collection of Blood, Bone Marrow, Skin Biopsies and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols Laboratory Research Studies
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Mycotic Ulcer Treatment Trial I
Mycotic Ulcer Treatment Trial
Status: Enrolling
Updated:  12/31/1969
Proctor Foundation, UCSF
mi
from
San Francisco, CA
Mycotic Ulcer Treatment Trial I
Mycotic Ulcer Treatment Trial
Status: Enrolling
Updated: 12/31/1969
Proctor Foundation, UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
Mycotic Ulcer Treatment Trial I
Mycotic Ulcer Treatment Trial
Status: Enrolling
Updated:  12/31/1969
Aravind Eye Hospitals
mi
from
Madurai,
Mycotic Ulcer Treatment Trial I
Mycotic Ulcer Treatment Trial
Status: Enrolling
Updated: 12/31/1969
Aravind Eye Hospitals
mi
from
Madurai,
Click here to add this to my saved trials
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
Status: Enrolling
Updated:  12/31/1969
Proctor Foundation, UCSF
mi
from
San Francisco, CA
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
Status: Enrolling
Updated: 12/31/1969
Proctor Foundation, UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
Status: Enrolling
Updated:  12/31/1969
Aravind Eye Hospital
mi
from
Coimbatore,
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
Status: Enrolling
Updated: 12/31/1969
Aravind Eye Hospital
mi
from
Coimbatore,
Click here to add this to my saved trials
Trichomoniasis: Genotype and Phenotype Correlations in African American Women
Trichomoniasis: Genotype and Phenotype Correlations in African American Women
Status: Enrolling
Updated:  12/31/1969
Women's Specialty Clinic at Mirror Lake
mi
from
Flowood, MS
Trichomoniasis: Genotype and Phenotype Correlations in African American Women
Trichomoniasis: Genotype and Phenotype Correlations in African American Women
Status: Enrolling
Updated: 12/31/1969
Women's Specialty Clinic at Mirror Lake
mi
from
Flowood, MS
Click here to add this to my saved trials
Trichomoniasis: Genotype and Phenotype Correlations in African American Women
Trichomoniasis: Genotype and Phenotype Correlations in African American Women
Status: Enrolling
Updated:  12/31/1969
University Physicians Grants Ferry
mi
from
Flowood, MS
Trichomoniasis: Genotype and Phenotype Correlations in African American Women
Trichomoniasis: Genotype and Phenotype Correlations in African American Women
Status: Enrolling
Updated: 12/31/1969
University Physicians Grants Ferry
mi
from
Flowood, MS
Click here to add this to my saved trials
Trichomoniasis: Genotype and Phenotype Correlations in African American Women
Trichomoniasis: Genotype and Phenotype Correlations in African American Women
Status: Enrolling
Updated:  12/31/1969
University Physicians Jackson Medical Mall
mi
from
Jackson, MS
Trichomoniasis: Genotype and Phenotype Correlations in African American Women
Trichomoniasis: Genotype and Phenotype Correlations in African American Women
Status: Enrolling
Updated: 12/31/1969
University Physicians Jackson Medical Mall
mi
from
Jackson, MS
Click here to add this to my saved trials
Trichomoniasis: Genotype and Phenotype Correlations in African American Women
Trichomoniasis: Genotype and Phenotype Correlations in African American Women
Status: Enrolling
Updated:  12/31/1969
Crossroads Clinics
mi
from
Jackson, MS
Trichomoniasis: Genotype and Phenotype Correlations in African American Women
Trichomoniasis: Genotype and Phenotype Correlations in African American Women
Status: Enrolling
Updated: 12/31/1969
Crossroads Clinics
mi
from
Jackson, MS
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Fayetteville, AR
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Anaheim, CA
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Honolulu, HI
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Honolulu, HI
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Louisville, KY
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Louisville, KY
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Charleston, SC
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Salt Lake City, UT
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Dothan, AL
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Dothan, AL
Click here to add this to my saved trials
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Benton, AR
Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants
Phase III, Partially Double-blind Study to Evaluate Consistency and Immunogenicity of 3 Lots of GSK Biologicals' Hib Conjugate Vaccine 208108 Versus ActHIB and Pentacel at 2, 4, 6 and 15-18 Months of Age in Healthy Infants
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Benton, AR
Click here to add this to my saved trials